WHAT'S KNOWN ON THIS SUBJECT: Saturations from pulse oximetry (SpO 2 ) may overestimate arterial oxygen saturations measured by CO-oximetry (SaO 2 ). The overestimation can be affected by location of measurement, perfusion, and skin color. Previous studies are limited by small numbers of observations in a hypoxemic range.
Practitioners frequently make decisions for children based on oxygen saturations obtainedfrompulseoximetry.Interventions such as supplemental oxygen, diuretics, or transfer to a higher level of care frequently occur without an arterial blood gas (ABG). Pulse oximeter performance has an impact on clinical decisions.
Pulse oximeters are developed to perform optimally in a range of oxyhemoglobin saturation from 70% to 100%. The US Food and Drug Administration (FDA) requires documentation of pulse oximeter accuracy defined as accuracy root mean squared (A rms ) ,3% with an equal number of samples in the decile range of 70% to 100% from adult volunteers through the standard ISO 80601-2-61:2011. 1 As indicated in the FDA' s document "Pulse Oximeters -Premarket Notification Submissions [510(k)s]" 2 for devices intended for use with neonates, the FDA recommends performance reports using adult subjects. Additional convenience arterial samples obtained in neonates are recommended when the sensor is new or significantly changed compared with previous devices. It is unclear how well pulse oximeters perform when the majority of observations are in children in a hypoxemic range. Previous work in children has been limited by small samples of observations in a hypoxemic range. However, these earlier manuscripts indicate SpO 2 may systematically overestimate measured arterial oxygen saturation from ABG sampling. 3, 4 The SpO 2 overestimation may also be dependent on location of measurement, 4, 5 perfusion to the extremity where the pulse oximeter is located, and skin color. 6, 7 The population of children with lower baseline oxygen saturations is growing. There are many children with cyanotic congenitalheartdisease(CCHD)undergoing and surviving palliative procedures. In addition, practitioners frequently manage children with acute hypoxemic respiratory failure (AHRF) without arterial catheters. 8 In these children, practitioners often increase ventilator support and fraction of inspired oxygen when the oxygen saturation falls out of an acceptable range (,87%). Although some manufacturers have developed pulse oximeters with hypoxemic measurements in mind (Masimo Blue Sensors, Nellcor LoSat Sensors), these sensors are not routine in most hospitals.
The primary objective of this study was to determine the performance of pulse oximetry for children in the range of 65% to 97% compared with arterial oxygen saturation measurements from CO-oximetry (SaO 2 ). To overcome limitations with a single measure of bias or precision over the entire range of pulse oximetry, the mean bias, local bias, precision, and A rms are reported. The secondary objective was to explore clinical scenarios in which pulse oximetry may be less reliable.
METHODS

Patients
A prospective, observational study in 5 US multidisciplinary PICUs was conducted from August 2009 to October 2010. The participating PICUs were Children' s Hospital Los Angeles, Penn State Children' s Hospital, University of Virginia Children' s Hospital, Monroe Carell Children' s Hospital, and Cohen Children' s Medical Center of New York. Patients were eligible if they were intubated, mechanically ventilated, had an arterial catheter, had SpO 2 values #97%, and were $37 weeks' gestational age and ,18 years. Patients were excluded if they were receiving extracorporeal membrane oxygenation or were not on a fully supported mode of ventilation. Continuous pulse oximeter recordings were standard of care in all PICUs. Patient demographics were obtained on enrollment and included age, race/ethnicity, gender, weight, and diagnosis. Patients were identified as to whether they had CCHD or AHRF. All participating PICUs had institutional review board approval with waiver of written consent. 9 
Measurements
The decision to obtain an ABG sample with CO-oximetry was left to the primary care team. The bedside provider was trained by a member of the research team before any data collection. Sensor cleanliness and position were verified before obtaining the ABG. The SpO 2 value was prospectively documented at the precise time the ABG was obtained (ABG/SpO 2 pair). ABG/SpO 2 pairs were not recorded if SpO 2 was .97% or there was endotracheal tube suctioning in the 10 minutes before or ventilator changes in the 30 minutes before the ABG. The ABG/SpO 2 pair was not recorded if the pulse oximeter value was not stable before the ABG or if there was concern about the waveform quality. For inclusion in the analysis, SaO 2 was measured using CO-oximetry. The blood gas machines used in the study were the ABL800 (Radiometer Medical Aps, Brønshøj, Denmark), Rapidlab 1265 (Siemens Healthcare, Erlangen, Germany), and Gem 3000 (Instrumentation Laboratory, Lexington, MA).
Additional information recorded with each ABG/SpO 2 pair included temperature, capillary refill in the extremity with the sensor, hemoglobin, pulse oximeter type, end tidal carbon dioxide, and degree of ventilator support. If the patient had CCHD with a physiology that was dependent on flow through a patent ductus arteriosus and there was a difference in pre-and postductal oxygen saturation, the protocol required that the pulse oximeter sensor and the arterial line were on the same side of the ductus. Ventilator information included peak inspiratory pressure, positive end expiratory pressure, pressure support, rate, exhaled tidal volume, mean airway pressure, fraction of inspired oxygen, and mode. Hemoglobin values were recorded from laboratory samples, and when unavailable, they were obtained from the ABG. Masimo pulse oximeters with the LCNS line of probes (Masimo Corporation, Irvine, CA) were used by 2 PICUs and Nellcor pulse oximeters with the OxiMax line of probes (Covidien-Nellcor, Boulder, CO) were used by 2 PICUs. One PICU used Masimo oximeters with the Nellcor OxiMax line of disposable probes.
Terms
To describe pulse oximeter performance, itishelpfultoreviewafewstatisticalterms commonly used: bias, precision, accuracy, and A rms . Bias is the SpO 2 -SaO 2 . SaO 2 as the reference standard from an ABG measured via CO-oximetry. Mean bias is the average SpO 2 -SaO 2 using all study observations, over the entire range, and is influenced by where the preponderance of pulse oximetry measurements lies. Local bias is mean SpO 2 -SaO 2 over a specific range of SpO 2 . Precision is typically 1 SD above and below the mean bias, describing how much random error is in the data. Methods to calculate precision require the bias to be normally distributed, which may not always be true. The limits of agreement are usually taken as 1.96 times the SD unless there is correction for repeated measures. The term "accuracy" is a measure of how far a value is from a reference standard. However, pulse oximeter companies generally present A rms , which is required by agencies that regulate pulse oximeters. The A rms combines the components of bias and precision controlling for the number of samples obtained. A rms of #3% is required by the FDA.
Analysis
The primary objective of this study was to evaluate the accuracy of simultaneous samples of SpO 2 compared with SaO 2 obtained by CO-oximetry throughout a range of SpO 2 values. Additional objectives were to identify variables that may affect the bias of SpO 2 compared with SaO 2 in the hypoxemic range. Statistical analysis was performed by using Stata version 10 (StataCorp, College Station, TX) and Statistica version 9 (Statsoft, Tulsa, OK).
Overall bias was assessed with a scatter plot of SpO 2 against SaO 2 . Local bias was assessed via a box-and-whisker plot examining the difference between SpO 2 and SaO 2 in 7 SpO 2 ranges. To explore inaccuracy, a bar graph was generated of counts of ABG/SpO 2 pairs in which the absolute value of (SpO 2 -SaO 2 ) is #3% and .3% as a function of SpO 2 range. Precision was reported with SD. However, because residuals were not normally distributed, median and interquartile range of (SpO 2 -SaO 2 ) as a whole and for each SpO 2 range were reported. A rms was calculated from the formula
as a whole and for each SpO 2 range.
To evaluate the potential influence of clinical variables on pulse oximetry bias, the ABG/SpO 2 pairs were separated into groups based on absolute value of the bias of #3% or .3%. This separation was used to perform a multivariate logistic regression analysis using a mixed model to examine the effect of other potential confounding variables and to control for repeated measures per patient. The confounding variables included disease category, gender, oximeter and sensor type, capillary refill in the extremity with the pulse oximeter, hemoglobin, temperature, and degree of ventilator support. Confounders were considered for model inclusion if they had a univariate relationship with the outcome (P , .2) or if there was strong biologic plausibility to suspect that they may influence the relationship between SpO 2 and SaO 2 (eg, capillary refill).
Finally, to explore whether multiple measurements per subject biased the results, data were filtered to randomly extract a single ABG/SpO 2 pair from each patient that fell within the SpO 2 ranges previously identified. Values for bias and precision (SD) using only 1 sample per patient per range were calculated and compared with the entire data set.
RESULTS
Two hundred twenty-five children were enrolled with 1980 ABG/SpO 2 pairs. The median number of ABG/SpO 2 pairs per patient was 5, interquartile range (2-10), range Values for SpO 2 are plotted against SaO 2 for all ABG/SpO 2 pairs in Fig 1. A total of 1304 of the 1980 samples (66%) had a positive bias (SpO 2 -SaO 2 . 0). Although the data were not normally distributed, mean and SD are presented to be consistent with other studies. For the entire SpO 2 range 65% to 97% the mean bias was 3.3%, median 2%, the precision (SD) 5.6%, interquartile range (0%-6%), and the A rms 6.5% (Table 3) .
Smaller Ranges of SpO 2
There were significant differences in bias, precision (SD), and accuracy based on SpO 2 range. The local bias (SpO 2 -SaO 2 ) was lowest in the SpO 2 ranges of 65% to 70% and 96% to 97% with median values of 0% and greatest in the SpO 2 range of 81% to 85% with a median value of 6% (Fig 2) . Precision (SD) and A rms were worst in the SpO 2 range of 81% to 85%, with poor accuracy in all ranges ,91% ( Table 3 ).
The data were filtered to randomly extract a single ABG/SpO 2 pair from each patient that fell within the SpO 2 ranges. Five hundred twenty-six ABG/SpO 2 pairs remained with a mean bias of 2.8%, median 2%, precision (SD) 5.6%, interquartile range (-1% to 6%), and A rms was 6.3% (nearly identical to values including repeated measurements). Findings were also similar within each of the SpO 2 ranges (analysis not shown).
Multivariate Modeling
The ABG/SpO 2 pairs were separated into 2 groups based on whether the absolute value of the bias was #3% or .3% (Table 4) . For ABG/SpO 2 pairs in which the bias was .3%, children with CCHD accounted for 78% of the samples (719 of 922) compared with children with AHRF (P , .001). The proportion of instances when the bias is .3% is highest in the midrange of SpO 2 (75%-90%; Fig 3) .
From multivariate modeling, variables associated with higher likelihood of bias .3% include CCHD, prolonged capillary refill, and having a SpO 2 between 81% to 85%, 86% to 90%, or 91% to 95% (compared with a SpO 2 of 96% to 97%; Table 5 ). Variables associated with a lower likelihood of bias were African American race/ethnicity, male gender, and the combination of Masimo oximeter with a Nellcor sensor. After controlling for these variables, mean airway pressure, hemoglobin, PICU site, temperature, fraction of inspired oxygen, age ,2 months, other races/ethnicity, and other oximeter combinations did not contribute to the model.
Because the majority of observations in the lower ranges of SpO 2 came from children with CCHD, a second multivariate model was performed restricted to only the subgroup of children with CCHD. Overall results were similar with a higher likelihood of bias associated with prolonged capillary refill and SpO 2 ranges of 81% to 85% and 86% to 90%. Furthermore, a lower likelihood of bias was associated with African American race/ethnicity and male gender.
DISCUSSION
There is significant variability in the bias, precision (SD) and accuracy of pulse oximetry as a function of SpO 2 . SpO 2 on average overestimates SaO 2 measured with CO-oximetry. This local bias is most positive in the SpO 2 range The multivariate model shows that pulse oximetry performs less well in children with CCHD and prolonged capillary refill. Children with CCHD were the largest proportion in the SpO 2 range from 81% to 85%, although this range remained the most likely for bias even when restricting the analysis only to children with CCHD. Therefore, it appears the inaccuracy is most related to the range of SpO 2 and not the presence of CCHD. Prolonged capillary refill makes physiologic sense because greater bias is anticipated with poorer Presented are count of ABG/SpO 2 pairs, median bias, interquartile range (IQR), mean bias, SD, and A rms presented for SpO 2 65% to 97% and subset ranges.
perfusion. 3 Age ,2 months showed a univariate effect, but this was not supported by the regression model. Age was meant as a surrogate for fetal hemoglobin, which may also be partially captured by other elements of the multivariate model. African American race/ethnicity and male gender were associated with lower likelihood of bias of the pulse oximeter. It is unclear what conclusions can be drawn from this. Race/ethnicity but not degree of skin color was recorded. There is no clear biological mechanism in which gender should have an impact on pulse oximetry performance. It is possible these are surrogates for an unmeasured confounding variable. Although pulse oximeters are marketed as meeting standards of accuracy throughout a range of oxygen saturations, this study highlights the need for manufacturers to present more data than the A rms for the entire range. Because mean bias and A rms will be influenced by large number of samples with SpO 2 values .91%, where pulse oximeters perform best, a single number for accuracy does not tell the entire picture. Furthermore, accuracy of pulse oximetry algorithms are often demonstrated using adult healthy volunteers breathing a hypoxic gas mixture, which is not the clinical environment in which they are used.
The local bias, precision (SD), and accuracy values presented are much larger than anticipated. The data for this study were acquired in a clinical setting, in the context of a reasonably controlled research study. Accuracy of pulse oximetry algorithms are generally demonstrated in a laboratory setting using adult healthy volunteers breathing a hypoxic gas mixture. This study was unable to meet the rigorous conditions of a research laboratory setting, 13 but the findings highlight the real-world clinical application of this scenario. Although it is not reasonable to generate hypoxia in children to produce an improved algorithm for pulse oximetry, there are pediatric cardiac surgery centers with large numbers of patients with CCHD. Perhaps future development could occur with a population such as this to generate algorithms that are more accurate for all children.
There are limitations to this study. First, the multicenter nature of the study increases generalizability, but the results may be confounded by institutional variation. For example, in 1 hospital, a sensor was used that was different from the manufacturer of the oximeter machine, making it difficult to determine the source of inaccuracy. However, this is a real-world situation, and results from that hospital were not large enough to skew the overall trend. Subgroup analysis by pulse oximeter brand was not performed because the majority of samples were measured with 1 oximeter brand. However, there was similar SpO 2 overestimation in the second manufacturer, and in that subgroup, this sample size is as large as any previously reported. Moreover, pulse oximetry type (except the combination of Masimo oximeter and Nellcor sensor) was not significant in the multivariate model.
A second limitation is that the data were collected using a waiver of consent. In turn, no patient-identifying information was retained, preventing us from gathering variables not initially included in the study. Such examples include perfusion index, location of pulse oximeter probe, amount of fetal hemoglobin, presence of other hemoglobin species, use of inotropic medications, presence of a patent ductus arteriosus, and pulse pressure. These are potential confounding variables that were not captured. These areas should be investigated in future studies with pulse oximetry. 
FIGURE 3
Count of ABG/SpO 2 pairs by absolute value of the bias #3% or .3% over SpO 2 range. The proportion of observation varies over the range with an increased number at higher SpO 2. The effect of local bias would be missed if the entire range were presented as a single number. 
CONCLUSIONS
Pulse oximeters appear to be accurate against CO-oximetry in a higher SpO 2 range such as .91%. However, in the lower SpO 2 range (76%-90%), the local bias (SpO 2 -SaO 2 ) is ∼5% and the precision (SD) and accuracy are poor when SpO 2 is ,90%. The manufacturers of these devices should improve algorithms in this range.
